secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001437749-23-017990
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Diffusion Pharmaceuticals appoints General Counsel William Elder as principal financial officer
--------------------------------------------------------------------------------

- William Elder, previously General Counsel and Corporate Secretary, appointed principal financial officer effective June 14, 2023.
- No changes to Elder's existing employment agreement, equity awards, or compensation in connection with the appointment.
- No arrangements or understandings with any other person regarding Elder's selection; no family relationships with directors or officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774923017990/0001437749-23-017990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774923017990/dffn20230621_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-017990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer